← Eichor
Study identifier: NCT04472702 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Fluoroscopic Versus Ultrasound Guidance for Cooled Radiofrequency Ablation of Geniculate Nerves in Knee Osteoarthritis: A Randomized Control Trial

Condition: Knee Osteoarthritis  ·  Sponsor: University of California, Davis

PhaseNA
Planned participants90
Who can joinAll sexes, 35 Years to 99 Years
Healthy volunteersNo

About this study

Cooled radiofrequency ablation (cRFA) of the knee geniculate nerves is a promising treatment option for knee osteoarthritis, but has variable efficacy. Fluoroscopy is the typical guidance of choice, but uses bony landmarks to target these nerves which have variable positions around the knee. Alternatively, ultrasound allows for targeting based on visualization of bony landmarks, the nerves, and their accompanying vascular structures, and thus may offer greater accuracy. However, there are few studies which directly compare the clinical efficacy of these two guidance options. This study will compare these two options.

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Herman, MD  ·  916-734-6805  ·  dcherman@ucdavis.edu

Katherine Rizzone, MD  ·  585-341-9407  ·  katherine_rizzone@urmc.rochester.edu

Always discuss trial participation with your own doctor first.

Locations (2)

UC Davis HealthSacramento, California, United StatesNot Yet Recruiting
University of RochesterRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04472702